针对多发性骨髓瘤的RNA疗法及其输送策略的进展
Kaiwen Luo1, Zhongkun Zhang2, Siyu Yao3
1Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
RNA疗法为治疗多发性骨髓瘤 (MM) 提供了新的希望,多发性骨髓瘤是一种患者经常复发的血液癌症. 本综述探讨了RNA标和输送系统,以克服耐药性并改善患者的治疗结果.
科学领域:
- 血液学恶性瘤是什么
- 癌症治疗方法 癌症治疗方法
- 医学RNA医学RNA医学
背景情况:
- 多发性骨髓瘤 (MM) 是一种无法治愈的血液癌症,经常复发且耐治疗.
- 目前的疗法,包括小分子,抗体和细胞疗法,由于MM细胞异质性和药物耐药性机制的演变而面临限制.
- 迫切需要新的治疗策略来改善多发性骨髓瘤患者的治疗结果.
研究的目的:
- 对多发性骨髓瘤 (MM) 基于RNA的治疗方法的治疗潜力进行审查.
- 确定MM中RNA治疗药物的有效核酸标和有效的输送系统.
- 讨论在MM治疗中RNA模式的临床转化面临的挑战和机遇.
主要方法:
- 对当前多发性骨髓瘤 (MM) 治疗方法和挑战的文献综述.
- 探索RNA疗法作为MM的新疗法.
- 对MM相关的潜在RNA目标和传递系统的分析.
主要成果:
- 通过抑制或上调MM细胞中的特定RNA序列,RNA疗法显示出有前途.
- 涉及RNA剂的组合疗法可能会增强MM细胞对现有治疗方法的敏感性.
- 关键的挑战包括确定最佳的RNA目标和开发MM的高效传递系统.
结论:
- RNA疗法是克服多发性骨髓瘤 (MM) 耐药性的有希望的途径.
- 对特定的分子标和传递系统的进一步研究对于临床翻译至关重要.
- 准MM细胞中异常表达的RNA具有显著的治疗潜力,可以改善全球患者的治疗结果.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics
Tumor Immunotherapy
